| argenx Switzerland SA - Vyvgart 1000 mg/ 5.6 ml, solution injectable | | 69725 | | 01 | | Vyvgart 1000 mg/ 5.6 ml | | solution injectable | | L04AA58 | | | | 10.02.2025 | | |
| | Composition | | efgartigimodum alfa 1000 mg, hyaluronidasum humanum ADNr, histidinum, histidini hydrochloridum monohydricum, dl-methioninum, natrii chloridum corresp. natrium 12.9 mg, saccharum, polysorbatum 20, aqua ad iniectabile q.s. ad solutionem pro 5.6 ml. | | Packungsbestandteile | | Solution injectable | | | | | | Principe actif | Concentr. |
|---|
| Efgartigimodum Alfa | 1000mg / 5.6ml |
| | | | Agents auxilliaires |
|---|
| DL-Methionine | | Histidin Hydrochloride Monohydrate | | Histidine | | Hyaluronidasum Humanum Adnr | | Sodium Chlorure | | Polysorbatum 20 | | Saccharum |
|
| | numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 001 | | DDP | DDP | A | | Non |
|
|
